Animal Models of Fragile X Syndrome: Mice and Flies

Genetic Instabilities and Neurological Diseases

Volumn , Issue , 2006, Pages 175-193

  Oostra, Ben A ^a   Nelson, David L ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84860327939     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369462-1/50012-0     Document Type: Chapter

References (116)

1. Hagerman R.J. The physical and behavioural phenotype. Fragile X Syndrome: Diagnosis, Treatment and Research 2002, 3-109. Johns Hopkins Univ. Press, Baltimore. R.J. Hagerman, P. Hagerman (Eds.).
2. Verkerk A.J., Pieretti M., Sutcliffe J.S., Fu Y.H., Kuhl D.P., Pizzuti A., Reiner O., Richards S., Victoria M.F., Zhang F.P., et al. Identification of a gene TMR-1 containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991, 65:905-914.
3. Oberlé I., Rousseau F., Heitz D., Kretz C., Devys D., Hanauer A., Boue J., Bertheas M.F., Mandel J.L. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 1991, 252:1097-1102.
4. Sutcliffe J.S., Nelson D.L., Zhang F., Pieretti M., Caskey C.T., Saxe D., Warren S.T. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum. Mol. Genet. 1992, 1:397-400.
5. Chiurazzi P., Pomponi M.G., Pietrobono R., Bakker C.E., Neri G., Oostra B.A. Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. Hum. Mol. Genet. 1999, 8:2317-2323.
6. Coffee B., Zhang F., Warren S.T., Reines D. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat. Genet. 1999, 22:98-101.
7. Pieretti M., Zhang F.P., Fu Y.H., Warren S.T., Oostra B.A., Caskey C.T., Nelson D.L. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 1991, 66:817-822.
8. Darnell J.C., Jensen K.B., Jin P., Brown V., Warren S.T., Darnell R.B. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 2001, 107:489-499.
9. Schaeffer C., Bardoni B., Mandel J.L., Ehresmann B., Ehresmann C., Moine H. The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif. EMBO J. 2001, 20:4803-4813.
10. Darnell J.C., Fraser C.E., Mostovetsky O., Stefani G., Jones T.A., Eddy S.R., Darnell R.B. Kissing complex RNAs mediate interaction between the fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes Dev. 2005, 19:903-918.
11. Siomi M.C., Siomi H., Sauer W.H., Srinivasan S., Nussbaum R.L., Dreyfuss G. FXR1, an autosomal homolog of the fragile X mental retardation gene. EMBO J. 1995, 14:2401-2408.
12. Zhang Y., Oconnor J.P., Siomi M.C., Srinivasan S., Dutra A., Nussbaum R.L., Dreyfuss G. The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. EMBO J. 1995, 14:5358-5366.
13. Kirkpatrick L.L., McIlwain K.A., Nelson D.L. Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2. Genomics 2001, 78:169-177.
14. Hagerman R.J., Hagerman P.J. Clinical and genetic features of myotonic dystrophy type 2. Genetic Instabilities and Neurological Diseases 2006, Ch. 10, Elsevier, Burlington, MA. R.D. Wells, T. Ashizawa (Eds.).
15. Sherman S.L. Premature ovarian failure among fragile X premutation carriers: Parent-of-origin effect?. Am. J. Hum. Genet. 2000, 67:11-13.
16. Tassone F., Hagerman P.J. Expression of the FMR1 gene. Cytogenet. Genome Res. 2003, 100:124-128.
17. Kenneson A., Zhang F., Hagedorn C.H., Warren S.T. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum. Mol. Genet. 2001, 10:1449-1454.
18. Primerano B., Tassone F., Hagerman R.J., Hagerman P., Amaldi F., Bagni C. Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. RNA 2002, 8:1-7.
19. Allen E.G., He W., Yadav-Shah M., Sherman S.L. A study of the distributional characteristics of FMR1 transcript levels in 238 individuals. Hum. Genet. 2004, 114:439-447.
20. Hagerman P.J., Hagerman R.J. The fragile-X premutation: A maturing perspective. Am. J. Hum. Genet. 2004, 74:805-816.
21. Hagerman P.J., Hagerman R.J. Fragile X-associated tremor/ataxia syndrome (FXTAS). Ment. Retard. Dev. Disabil. Res. Rev. 2004, 10:25-30.
22. Jacquemont S., Hagerman R.J., Leehey M., Grigsby J., Zhang L., Brunberg J.A., Greco C., Des Portes V., Jardini T., Levine R., et al. Fragile X premutation tremor/ataxia syndrome: Molecular, clinical, and neuroimaging correlates. Am. J. Hum. Genet. 2003, 72:869-878.
23. Hagerman P.J., Greco C.M., Hagerman R.J. A cerebellar tremor/ataxia syndrome among fragile X premutation carriers. Cytogenet. Genome Res. 2003, 100:206-212.
24. Bakker C.E., Verheij C., Willemsen R., Vanderhelm R., Oerlemans F., Vermey M., Bygrave A., Hoogeveen A.T., Oostra B.A., Reyniers E., et al. Fmr1 knockout mice: A model to study fragile X mental retardation. Cell 1994, 78:23-33.
25. Ashley C.T., Sutcliffe J.S., Kunst C.B., Leiner H.A., Eichler E.E., Nelson D.L., Warren S.T. Human and murine FMR-1: Alternative splicing and translational initiation down-stream of the CGG-repeat. Nat. Genet. 1993, 4:244-251.
26. Hinds H.L., Ashley C.T., Sutcliffe J.S., Nelson D.L., Wrren S.T., Housman D.E., Schalling M. Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat. Genet. 1993, 3:36-43.
27. Khandjian E.W., Fortin A., Thibodeau A., Tremblay S., Cote F., Devys D., Mandel J.L., Rousseau F. A heterogeneous set of FMR1 proteins is widely distributed in mouse tissues and is modulated in cell culture. Human Mol Genet 1995, 4:783-790.
28. Bakker C.E., de Diego Otero Y., Bontekoe C., Raghoe P., Luteijn T., Hoogeveen A.T., Oostra B.A., Willemse R. Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse. Exp. Cell Res. 2000, 258:162-170.
29. De Diego Otero Y., Bakker C.E., Raghoe P., Severijnen L.W.F.M., Hoogeveen A., Oostra B.A., Willemsen R. Immunocytochemical characterization of FMRP, FXR1P and FXR2P during embryonic development in the mouse. Gene Funct. Dis. 2000, 1:28-37.
30. Kooy R.F., Dhooge R., Reyniers E., Bakker C.E., Nagels G., Deboulle K., Storm K., Clincke G., Dedeyn P.P., Oostra B.A., et al. Transgenic mouse model for the fragile X syndrome. Am. J. Med. Genet. 1996, 64:241-245.
31. Willems P.J., Reyniers E., Oostra B.A. An animal model for fragile X syndrome. Mental Retard. Dev. Disabil. Res. Rev. 1995, 1:298-302.
32. Mientjes, E. J., Nieuwenhuizen, I., Kirkpatrick, L., Zu, T., Hoogeveen-Westerveld, M., Severijnen, L., Willemsen, R., Nelson, D. L., and Oostra, B. A. The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo. Neurobiol. Dis., Epub Oct 2005.
33. Reyniers E., Vits L., De Boulle K., Van Roy B., Van Velzen D., de Graaff E., Verkerk A.J.M.H., Jorens H.Z., Darby J.K., Oostra B.A., et al. The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nat. Genet. 1993, 4:143-146.
34. Slegtenhorst-Eegdeman K.E., van de Kant H.J.G., Post M., Ruiz A., Uilenbroek J.T.J., Bakker C.E., Oostra B.A., Grootegoed J.A., de Rooij D.G., Themmen A.P.N. Macro-orchidism in FMR1 knockout mice is caused by increased Sertoli cel proliferation during testis development. Endocrinology 1998, 139:156-162.
35. Sharpe R.M. Experimental Evidence for Sertoli-Germ Cell and Sertoli-Leydig Cell Interactions. The Sertoli Cell 1993, 391-418. Cache River Press, Clearwater, FL. L.D. Russell, M.D. Griswold (Eds.).
36. Kumar T.R., Wang Y., Lu N., Matzuk M.M. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat. Genet. 1997, 15:201-204.
37. Orth J.M. Proliferation of Sertoli cells in fetal and postnatal rats: A quantitative autoradiographic study. Anat. Rec. 1982, 203:485-492.
38. Moore P.S., Chudley A.E., Winter J.S. Pituitary-gonadal axis in prepubertal boys with the fragile X syndrome. Am. J. Med. Genet. 1991, 39:374-375.
39. Nielsen K.B., Tommerup N., Dyggve H.V., Schou C. Macroorchidism and fragile X in mentally retarded males: Clinical, cytogenetic, and some hormonal investigations in mentally retarded males, including two with the fragile site at Xq28, fra(X)(q28). Hum. Genet. 1982, 61:113-117.
40. Malter H.E., Iber J.C., Willemsen R., De Graaff E., Tarleton J.C., Leisti J., Warren S.T., Oostra B.A. Characterization of the full fragile X syndrome mutation in fetal gametes. Nat. Genet. 1997, 15:165-169.
41. Peier A.M., McIlwain K.L., Kenneson A., Warren S.T., Paylor R., Nelson D.L. (Over)correction of FMR1 deficiency with YAC transgenics: Behavioral and physical features. Hum. Mol. Genet. 2000, 9:1145-1159.
42. Bakker C.E., Oostra B.A. Understanding fragile X syndrome: Insights from animal models. Cytogenet. Genome. Res. 2003, 100:111-123.
43. Qin M., Kang J., Smith C.B. Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation. Proc. Natl. Acad. Sci. USA 2002, 99:15758-15763.
44. Qin M., Kang J., Burlin T.V., Jiang C., Smith C.B. Postadolescent changes in regional cerebral protein synthesis: An in vivo study in the FMR1 null mouse. J. Neurosci. 2005, 25:5087-5095.
45. Gruss M., Braun K. Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: A putative animal model of the human fragile X mental retardation syndrome. Neural Plast. 2001, 8:285-298.
46. Gruss M., Braun K. Age- and region-specific imbalances of basal amino acids and monoamine metabolism in limbic regions of female Fmr1 knock-out mice. Neurochem. Int. 2004, 45:81-88.
47. Ivanco T.L., Greenough W.T. Altered mossy fiber distributions in adult Fmr1 (FVB) knockout mice. Hippocampus 2002, 12:47-54.
48. Crusio W.E., Schwegler H. Hippocampal mossy fiber distribution covaries with open-field habituation in the mouse. Behav. Brain Res. 1987, 26:153-158.
49. Schwegler H., Crusio W.E. Correlations between radial-maze learning and structural variations of septum and hippocampus in rodents. Behav. Brain Res. 1995, 67:29-41.
50. Schwegler H., Crusio W.E., Brust I. Hippocampal mossy fibers and radial-maze learning in the mouse: A correlation with spatial working memory but not with non-spatial reference memory. Neuroscience 1990, 34:293-298.
51. Mineur Y.S., Sluyter F., de W.S., Oostra B.A., Crusio W.E. Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse. Hippocampus 2002, 12:39-46.
52. Rudelli R.D., Brown W.T., Wisniewski K., Jenkins E.C., Laure-Kaminnowska M., Connell F., Wisniewski H.M. Adult fragile X syndrome: Clinico-neuropathologic findings. Acta Neuropathol. 1985, 67:289-295.
53. Comery T.A., Harris J.B., Willems P.J., Oostra B.A., Irwin S.A., Weiler I.J., Greenough W.T. Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits. Proc. Natl. Acad. Sci. USA 1997, 94:5401-5404.
54. Irwin S.A., Patel B., Idupulapati M., Harris J.B., Crisostomo R.A., Larsen B.P., Kooy F., Willems P.J., Cras P., Kozlowski P.B., et al. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: A quantitative examination. Am. J. Med. Genet. 2001, 98:161-167.
55. Nimchinsky E.A., Oberlander A.M., Svoboda K. Abnormal development of dendritic spines in fmr1 knock-out mice. J. Neurosci. 2001, 21:5139-5146.
56. Koekkoek S.K., Yamaguchi K., Milojkovic B.A., Dortland B.R., Ruigrok T.J., Maex R., De Graaf W., Smit A.E., Vanderwerf F., Bakker C.E., et al. Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in fragile X syndrome. Neuron 2005, 47:339-352.
57. Irwin S.A., Idupulapati M., Gilbert M.E., Harris J.B., Chakravarti A.B., Rogers E.J., Crisostomo R.A., Larsen B.P., Mehta A., Alcantara C.J., et al. Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X knockout mice. Am. J. Med. Genet. 2002, 111:140-146.
58. Kakizawa S., Yamada K., Iino M., Watanabe M., Kano M. Effects of insulin-like growth factor I on climbing fibre synapse elimination during cerebellar development. Eur. J. Neurosci. 2003, 17:545-554.
59. Cesa R., Morando L., Strata P. Glutamate receptor delta2 subunit in activity-dependent heterologous synaptic competition. J. Neurosci. 2003, 23:2363-2370.
60. Weiler I.J., Irwin S.A., Klintsova A.Y., Spencer C.M., Brazelton A.D., Miyashiro K., Comery T.A., Patel B., Eberwine J., Greenough W.T. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc. Natl. Acad. Sci. USA 1997, 94:5395-5400.
61. Godfraind J.M., Reyniers E., Deboulle K., Dhooge R., Dedeyn P.P., Bakker C.E., Oostra B.A., Kooy R.F., Willems P.J. Long-term potentiation in the hippocampus of fragile X knockout mice. Am. J. Med. Genet. 1996, 64:246-251.
62. Paradee W., Melikian H.E., Rasmussen D.L., Kenneson A., Conn P.J., Warren S.T. Fragile X mouse: Strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neuroscience 1999, 94:185-192.
63. Li J., Pelletier M.R., Perez Velazquez J.L., Carlen P.L. Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency. Mol. Cell. Neurosci. 2002, 19:138-151.
64. Huber K.M., Gallagher S.M., Warren S.T., Bear M.F. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl. Acad. Sci. USA 2002, 99:7746-7750.
65. Dobkin C., Rabe A., Dumas R., El Idrissi A., Haubenstock H., Ted Brown W. Fmr1 knockout mouse has a distinctive strain-specific learning impairment. Neuroscience 2000, 100:423-429.
66. Musumeci S.A., Bosco P., Calabrese G., Bakker C., De Sarro G.B., Elia M., Ferri R., Oostra B.A. Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia 2000, 41:19-23.
67. Musumeci S.A., Hagerman R.J., Ferri R., Bosco P., Dalla Bernardina B., Tassinari C.A., De Sarro G.B., Elia M. Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia 1999, 40:1092-1099.
68. D'Hooge R., Nagels G., Franck F., Bakker C.E., Reyniers E., Storm K., Kooy R.F., Oostra B.A., Willems P.J., Dedeyn P.P. Mildly impaired water maze performance in male Fmr1 knockout mice. Neuroscience 1997, 76:367-376.
69. Morris R.G.M. Spatial localization does not require the presence of local clues. Learn. Motiv. 1981, 12:239-260.
70. Morris R.G., Garrud P., Rawlins J.N., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982, 297:681-683.
71. Chen L., Toth M. Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience 2001, 103:1043-1050.
72. Nielsen D.M., Derber W.J., McClellan D.A., Crnic L.S. Alterations in the auditory startle response in Fmr1 targeted mutant mouse models of fragile X syndrome. Brain Res. 2002, 927:8-17.
73. Van Dam D., D'Hooge R., Hauben E., Reyniers E., Gantois I., Bakker C.E., Oostra B.A., Kooy R.F., De Deyn P.P. Spatial learning, contextual fear conditioning and conditioned emotional response in Fmr1 knockout mice. Behav. Brain Res. 2000, 117:127-136.
74. Bear M.F., Huber K.M., Warren S.T. The mGluR theory of fragile X mental retardation. Trends Neurosci. 2004, 27:370-377.
75. Yan Q.J., Rammal M., Tranfaglia M., Bauchwitz R.P. Suppression of two major fragile X syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology 2005, 49:1053-1066.
76. Todd P.K., Mack K.J. Sensory stimulation increases cortical expression of the fragile X mental retardation protein in vivo. Brain Res. Mol. Brain Res. 2000, 80:17-25.
77. Todd P.K., Malter J.S., Mack K.J. Whisker stimulation-dependent translation of FMRP in the barrel cortex requires activation of type I metabotropic glutamate receptors. Brain Res. Mol. Brain Res. 2003, 110:267-278.
78. Gabel L.A., Won S., Kawai H., McKinney M., Tartakoff A.M., Fallon J.R. Visual experience regulates transient expression and dendritic localization of fragile X mental retardation protein. J. Neurosci. 2004, 24:10579-10583.
79. Irwin S.A., Swain R.A., Christmon C.A., Chakravarti A., Weiler I.J., Greenough W.T. Evidence for altered fragile-X mental retardation protein expression in response to behavioral stimulation. Neurobiol. Learn. Mem. 2000, 73:87-93.
80. Irwin S.A., Christmon C.A., Grossman A.W., Galvez R., Kim S.H., Degrush B.J., Weiler I.J., Greenough W.T. Fragile X mental retardation protein levels increase following complex environment exposure in rat brain regions undergoing active synaptogenesis. Neurobiol. Learn. Mem. 2005, 83:180-187.
81. Restivo L., Ferrari F., Passino E., Sgobio C., Bock J., Oostra B.A., Bagni C., Ammassari-Teule M. Enriched environment promotes behavioral and morphological recovery in a mouse model for the fragile X syndrome. Proc. Natl. Acad. Sci. USA 2005, 102:11557-11562.
82. Son L.S., Wells R.D. Triplexes, sticky DNA, and the (GAA TTC) trinucleotide repeat associated with Friedrich's ataxia. Genetic Instabilities and Neurological Diseases 2006, Ch. 20, Elsevier, Burlington, MA. R.D. Wells, T. Ashizawa (Eds.).
83. Bontekoe C.J.M., de Graaff E., Nieuwenhuizen I.M., Willemsen R., Oostra B.A. FMR1 premutation allele is stable in mice. Eur. J. Hum. Genet. 1997, 5:293-298.
84. Lavedan C., Grabczyk E., Usdin K., Nussbaum R.L. Long uninterrupted CGG repeast within the first exon of the human FMR1 gene are not intrinsically unstable in transgenic mice. Genomics 1998, 50:229-240.
85. Lavedan C.N., Garrett L., Nussbaum R.L. Trinucleotide repeats (CGG)22TGG(CGG)43TGG(CGG)21 from the fragile X gene remain stable in transgenic mice. Hum. Genet. 1997, 100:407-414.
86. Bontekoe C.J., Bakker C.E., Nieuwenhuizen I.M., van Der Linde H., Lans H., de Lange D., Hirst M.C., Oostra B.A. Instability of a (GGG)(88) repeat in the Fmr1 promoter. Hum. Mol. Genet. 2001, 10:1693-1699.
87. Willemsen R., Hoogeveen-Westerveld M., Reis S., Holstege J., Severijnen L., Nieuwenhuizen I., Schrier M., VanUnen L., Tassone F., Hoogeveen A., Hagerman P., Mientjes E., Oostra B.A. The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions: Implications for the cerebellar tremor/ataxia syndrome. Hum. Mol. Genet. 2003, 12:949-959.
88. Peier A., Nelson D. Instability of a premutation-sized CGG repeat in FMR1 YAC transgenic mice. Genomics 2002, 80:423-432.
89. Greco C.M., Hagerman R.J., Tassone F., Chudley A.E., Del Bigio M.R., Jacquemont S., Leehey M., Hagerman P.J. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 2002, 125:1760-1771.
90. Van Dam D., Errijgers V., Kooy R.F., Willemsen R., Mientjes E., Oostra B.A., De Deyn P.P. Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS). Behav. Brain Res. 2005, 162:233-239.
91. Tamanini F., Willemsen R., van Unen L., Bontekoe C., Galjaard H., Oostra B.A., Hoogeveen A.T. Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. Hum. Mol. Genet. 1997, 6:1315-1322.
92. Dube M., Huot M.E., Khandjian E.W. Muscle specific fragile X related protein 1 isoforms are sequestered in the nucleus of undifferentiated myoblast. BMC Genet. 2000, 1:1-4.
93. Kirkpatrick L.L., McIlwain K.A., Nelson D.L. Alternative splicing in the murine and human FXR1 genes. Genomics 1999, 59:193-202.
94. Khandjian E.W., Bardoni B., Corbin F., Sittler A., Giroux S., Heitz D., Tremblay S., Pinset C., Montarras D., Rousseau F., et al. Novel isoforms of the fragile X related protein FXR1P are expressed during myogenesis. Hum. Mol. Genet. 1998, 7:2121-2128.
95. Bontekoe C.J., McIlwain K.L., Nieuwenhuizen I.M., Yuva-Paylor L.A., Nellis A., Willemsen R., Fang Z., Kirkpatrick L., Bakker C.E., McAninch R., et al. Knockout mouse model for Fxr2: A model for mental retardation. Hum. Mol. Genet. 2002, 11:487-498.
96. Mientjes E.J., Willemsen R., Kirkpatrick L.L., Nieuwenhuizen I.M., Hoogeveen-Westerveld M., Verweij M., Reis S., Bardoni B., Hoogeveen A.T., Oostra B.A., et al. Fxr1 knockout mice show a striated muscle phenotype: Implications for Fxr1p function in vivo. Hum. Mol. Genet. 2004, 13:1291-1302.
97. Wan L., Dockendorff T.C., Jongens T.A., Dreyfuss G. Characterization of dFMR1, a Drosophila melanogaster homolog of the fragile X mental retardation protein. Mol. Cell. Biol. 2000, 20:8536-8547.
98. Zhang Y.Q., Bailey A.M., Matthies H.J., Renden R.B., Smith M.A., Speese S.D., Rubin G.M., Broadie K. Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell 2001, 107:591-603.
99. Morales J., Hiesinger P.R., Schroeder A.J., Kume K., Verstreken P.F., Rob Jackson F.R., Nelson D.L., Hassan B.A. Drosophila fragile X protein, DFXR, regulates neuronal morphology and function in the brain. Neuron 2002, 34:961-972.
100. Dockendorff T.C., Su H.S., McBride S.M.J., Yang Z., Choi C.H., Siwicki K.K., Sehgal A., Jongens T.A. Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest. Neuron 2002, 34:973-984.
101. Schenck A., Van de Bor V., Bardoni B., Giangrande A. Novel features of dFMR1, the Drosophila orthologue of the fragile X mental retardation protein. Neurobiol. Dis. 2002, 11:53-63.
102. Inoue S., Shimoda M., Nishinokubi I., Siomi M., Okamura M., Nakamura A., Kobayashi S., Ishida N., Siomi H. A role for the Drosophila fragile x-related gene in circadian output. Curr. Biol. 2002, 12:1331.
103. Xu K., Bogert B.A., Li W., Su K., Lee A., Gao F.B. The fragile X-related gene affects the crawling behavior of Drosophila larvae by regulating the mRNA level of the DEG/ENaC protein Pickpocket1. Curr. Biol. 2004, 14:1025-1034.
104. McBride S.M., Choi C.H., Wang Y., Liebelt D., Braunstein E., Ferreiro D., Sehgal A., Siwicki K.K., Dockendorff T.C., Nguyen H.T., et al. Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron 2005, 45:753-764.
105. Michel C.I., Kraft R., Restifo L.L. Defective neuronal development in the mushroom bodies of Drosophila fragile X mental retardation 1 mutants. J. Neurosci. 2004, 24:5798-5809.
106. Pan L., Zhang Y.Q., Woodruff E., Broadie K. The Drosophila fragile X gene negatively regulates neuronal elaboration and synaptic differentiation. Curr. Biol. 2004, 14:1863-1870.
107. Zhang Y.Q., Matthies H.J., Mancuso J., Andrews H.K., Woodruff E., Friedman D., Broadie K. The Drosophila fragile X-related gene regulates axoneme differentiation during spermatogenesis. Dev. Biol. 2004, 270:290-307.
108. Zarnescu D.C., Jin P., Betschinger J., Nakamoto M., Wang Y., Dockendorff T.C., Feng Y., Jongens T.A., Sisson J.C., Knoblich J.A., et al. Fragile X protein functions with lgl and the par complex in flies and mice. Dev. Cell 2005, 8:43-52.
109. Lu R., Wang H., Liang Z., Ku L., O'Donnell W.T., Li W., Warren S.T., Feng Y. The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Proc. Natl. Acad. Sci. USA 2004, 101:15201-15206.
110. Schenck A., Bardoni B., Langmann C., Harden N., Mandel J.L., Giangrande A. CYFIP/Sra-1 controls neuronal connectivity in Drosophila and links the Rac1 GTPase pathway to the fragile X protein. Neuron 2003, 38:887-898.
111. Lee A., Li W., Xu K., Bogert B.A., Su K., Gao F.B. Control of dendritic development by the Drosophila fragile X-related gene involves in the small GTPase Rac1. Development 2003, 130:5543-5552.
112. Reeve S.P., Bassetto L., Genova G.K., Kleyner Y., Leyssen M., Jackson F.R., Hassan B.A. The Drosophila fragile X mental retardation protein controls actin dynamics by directly regulating profilin in the brain. Curr. Biol. 2005, 15:1156-1163.
113. Caudy A.A., Myers M., Hannon G.J., Hammond S.M. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev. 2002, 16:2491-2496.
114. Jin P., Alisch R.S., Warren S.T. RNA and microRNAs in fragile X mental retardation. Nat. Cell Biol. 2004, 6:1048-1053.
115. Zhang Y.Q., Friedman D.B., Wang Z., Woodruff E., Pan L., O'Donnell J., Broadie K. Protein expression profiling of the drosophila fragile X mutant brain reveals upregulation of monoamine synthesis. Mol. Cell. Proteomics 2005, 4:278-290.
116. Jin P., Zarnescu D.C., Zhang F., Pearson C.E., Lucchesi J.C., Moses K., Warren S.T. RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron 2003, 39:739-747.